SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 102 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $152,000 | -67.4% | 126,988 | -11.0% | 0.00% | – |
| Q4 2021 | $466,000 | -27.1% | 142,734 | -0.0% | 0.00% | – |
| Q3 2021 | $639,000 | -70.1% | 142,790 | -63.6% | 0.00% | -100.0% |
| Q2 2021 | $2,136,000 | -21.4% | 391,798 | +7.9% | 0.00% | 0.0% |
| Q1 2021 | $2,717,000 | +3.1% | 363,167 | +49.5% | 0.00% | 0.0% |
| Q4 2020 | $2,636,000 | +22.6% | 242,946 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $2,150,000 | -19.6% | 243,114 | -3.1% | 0.00% | 0.0% |
| Q2 2020 | $2,675,000 | +119.8% | 250,889 | +22.3% | 0.00% | 0.0% |
| Q1 2020 | $1,217,000 | -14.2% | 205,166 | -0.1% | 0.00% | 0.0% |
| Q4 2019 | $1,419,000 | -31.3% | 205,350 | +3.1% | 0.00% | 0.0% |
| Q3 2019 | $2,067,000 | +9.4% | 199,094 | -2.4% | 0.00% | 0.0% |
| Q2 2019 | $1,889,000 | +83.0% | 203,968 | +80.7% | 0.00% | 0.0% |
| Q1 2019 | $1,032,000 | +45.8% | 112,887 | -11.1% | 0.00% | 0.0% |
| Q4 2018 | $708,000 | -54.0% | 127,025 | -1.6% | 0.00% | 0.0% |
| Q3 2018 | $1,538,000 | +34.3% | 129,057 | +15.1% | 0.00% | 0.0% |
| Q2 2018 | $1,145,000 | +14.8% | 112,093 | +46.1% | 0.00% | 0.0% |
| Q1 2018 | $997,000 | +135.7% | 76,740 | +76.7% | 0.00% | – |
| Q4 2017 | $423,000 | -31.1% | 43,425 | +4.1% | 0.00% | -100.0% |
| Q3 2017 | $614,000 | +79.0% | 41,709 | +95.8% | 0.00% | – |
| Q2 2017 | $343,000 | – | 21,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
| Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
| Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
| Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
| EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
| Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
| Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
| Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
| Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |